Global Naloxone Spray Market ($1.94Bn by 2028) Growth Forecast at 20.1% CAGR During 2022 to 2028 COVID Impact and Global Analysis by Vantage Market Research


WASHINGTON, March 02, 2022 (GLOBE NEWSWIRE) -- Increasing prevalence of opioids overdose is expected to fuel the growth of Naloxone Spray Market. Rising cases of opioid drug abuse in the developed as well as developing nations is another factor driving the growth of Naloxone Spray Market. These are some of the advantages that generating demand for the Naloxone Spray Market, states Vantage Market Research, in a report, titled “Naloxone Spray Market by Dosage (2 mg/actuation, 4 mg/actuation, Others), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)”.

The market size stood at USD 0.32 Billion in 2021. The Global Naloxone Spray Market size is expected to reach USD 1.94 Billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 20.1% during the forecast period.

Please Check Out Our Free Sample Reports and Make a More Informed Decision:

Get Access to a Free Copy of Our Latest Sample Report @ https://www.vantagemarketresearch.com/naloxone-spray-market-1324/request-sample

(Sample reports are a great way to test our in-depth reports or study before you make a purchase)

  • The newly updated, 130+ page reports provide an in-depth analysis of the COVID-19 virus and pandemic.
  • Using industry data and interview with experts, you can learn about topics such as regional impact analysis, global forecast, competitive landscape analysis, size & share of regional markets.
  • We offer these reports in PDF format so you can read them on your computer and print them out.
  • Free sample includes, Industry Operating Conditions, Industry Market Size, Profitability Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast, Growth Porter's 5 Forces Analysis, Revenue Forecasts, Industry Trends, Industry Financial Ratios.
  • The report also presents the country-wise and region-wise analysis of the Vantage Market Research and includes a detailed analysis of the key factors affecting the growth of the market.
  • Sample Report further sheds light on the Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis, to offer the readers an advantage over others.

The report on Naloxone Spray Market highlights:

  • Assessment of the market
  • Premium Insights
  • Competitive Landscape
  • COVID Impact Analysis
  • Value Chain Analysis
  • Historic Data, Estimates and Forecast
  • Company Profiles
  • Porter’s Five Forces Analysis
  • Global and Regional Dynamics

Market Overview:

Recent Approvals by FDA for Using Naloxone Spray   

Recently launch and approval of novel naloxone products by various regulatory bodies is expected to be a major factor aiding in growth of the market over the forecast period. Naloxone is a medicine that can be administered by individuals with or without medical training to help reduce opioid overdose deaths. If naloxone is administered quickly, it can counter the opioid overdose effects, usually within minutes. A higher dose of naloxone provides an additional option in the treatment of opioid overdoses. For instance, in January 2017, the U.S. Food and Drug Administration (FDA) approved Adapt Pharma Inc.’s NARCAN Nasal Spray 2 mg formulation for emergency treatment of known or suspected opioid overdose. In 2016, Mylan N.V. launched its naloxone hydrochloride injection USP, 0.4 mg/mL packaged in 1 mL single-dose vials. It is therapeutically equivalent to the naloxone hydrochloride injection 0.4 mg/mL, of Hospira Inc.

Purchase This Premium Report Now @ https://www.vantagemarketresearch.com/buy-now/naloxone-spray-market-1324/1

Benefits of Purchasing Naloxone Spray Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Major Side Effects of Naloxone Spray Might Hinder

Use of Naloxone Spray has certain side effects which are likely to hinder the market to some extent. These include body aches, a fever, sweating, runny nose, sneezing, goose bumps, yawning, weakness, shivering or trembling, nervousness, restlessness or irritability, diarrhoea, nausea or vomiting, stomach cramps, fast heartbeat, and increased blood pressure. This medicine should be given immediately upon when a suspected or known overdose of an opioid has occurred. This will help prevent serious breathing problems and severe sleepiness that can lead to death.

COVID-19 Impact Analysis:

The COVID-19 outbreak has affected various industries worldwide. The Naloxone Spray Market also had a huge impact. Governments across the world took severe actions like border seals, lockdown, and implementing strict social distancing measures, in order to stop the swift spread of COVID-19. These actions led to a severe impact on the global economy impairing various industries. Moreover, reduced manufacturing activities further affected the demand for Naloxone Spray manufacturing across the globe.  The impact of COVID-19 on the market demand is considered while estimating the current and forecast market size and growth trends of the market for all the regions and countries based on the following data- points:

  1. Impact Assessment of COVID-19 Pandemic
    1. North America
    2. Europe
    3. Asia Pacific
    4. Latin America
    5. Middle East & Africa
  2. Quarterly Market Revenue Forecast by Region 2020 & 2021
  3. Key Strategies Undertaken by Companies to Tackle COVID-19
  4. Long Term Dynamics
  5. Short Term Dynamics

Read Full Research Report @ https://www.vantagemarketresearch.com/industry-report/naloxone-spray-market-1324

Regional Analysis:

Increasing Growth of Naloxone Spray Market in North America

North America accounted for the largest share of the Naloxone Spray Market in 2021. The large share of this region in the global Naloxone Spray Market can be attributed to the factors such as the rising prevalence breathing problems across globe. Countries such as India and China are highly polluted are prone to respiratory diseases. In coming years, the use of Naloxone Spray is expected to show positive result in this region.

The Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to the prevalence for increase in number of well-established Naloxone Spray companies and research institutes in the US and Canada. Also large number of on-going research studies and growth of the overall healthcare sector on a global scale are among the few factors expected to contribute to the growth of this market. For instance, in September 2017, Mundipharma International Limited received approval from European Medicines Agency (EMA) for its product (intranasal naloxone 1.8 mg) to use in emergency reversal of opioid overdose. Key players funding major Research and Development (R&D) facilities which are also one of the factors that are booming the development of Naloxone Spray Market in this region.    

Browse market data Tables and Figures spread through 133 Pages and in-depth TOC on "Naloxone Spray Market by Dosage (2 mg/actuation, 4 mg/actuation, Others), by Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Online Pharmacies), by Region (North America, Europe, Asia Pacific, Latin America) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)" View detailed Research Report here - https://www.vantagemarketresearch.com/press-release/naloxone-spray-market-687484

List of Prominent Players in the Naloxone Spray Market:

  • Emergent BioSolutions (US)
  • Pfizer (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Opiant Pharmaceuticals (US)
  • Hikma Pharmaceuticals (UK)
  • Nasus Pharma (Israel)
  • Amphastar Pharmaceuticals (US)
  • Indivior PLC (US)
  • Samarth Pharma Pvt. Ltd. (India)
  • Troikaa Pharmaceuticals Ltd. (India)
  • Neon Laboratories Limited (India)

 Key questions answered in the report:

  • Which regional market will show the highest and rapid growth?
  • Which are the top five players of the Naloxone Spray Market?   
  • How will the Naloxone Spray Market change in the upcoming six years?  
  • Which application and product will take a lion’s share of the Naloxone Spray Market?       
  • What is the Naloxone Spray market drivers and restrictions?    
  • What will be the CAGR and size of the Naloxone Spray Market throughout the forecast period?     

This market titled “Naloxone Spray Market” will cover exclusive information in terms of Regional Analysis, Forecast, and Quantitative Data – Units, Key Market Trends, and various others as mentioned below:

Report AttributeDetails
Market Size in 2021USD 0.32 Billion
Projected Market Size in 2028USD 1.94 Billion
CAGR Growth RateCAGR of 20.1% From 2022 – 2028
Base Year2021
Historic Years2016 - 2020
Forecast Years2022 - 2028
Segments CoveredDosage

  • 2 mg/actuation
  • 4 mg/actuation
  • Others
Distribution Channel
  • Hospitals
  • Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Quantitative Data - UnitsRevenue in USD Million/Billion and CAGR from 2021 to 2028
Regions CoveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries CoveredU.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Report CoverageMarket growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.

Customization of the Report:

The report can be customized as per client needs or requirements. For any queries, you can contact us on sales@vantagemarketresearch.com or +1 (202) 380-9727. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.

Download Free Sample Report Now @ https://www.vantagemarketresearch.com/naloxone-spray-market-1324/request-sample

Browse More Related Report:

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.

Follow Us: LinkedIn | Twitter

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website: https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases @ https://www.vantagemarketresearch.com/insight/press-releases

Latest Vantage Market Research Blog @ https://www.vantagemarketresearch.com/insight/blogs

Blog: